Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells

Journal of Biological Chemistry

Volumn 290, Issue 7, 2015, Pages 3925-3935

  Wang, Xinyu ^a   Li, Meng ^a   Wang, Zhiqiong ^a   Han, Sichong ^a   Tang, Xiaohu ^a   Ge, Yunxia ^a   Zhou, Liqing ^b   Zhou, Changchun ^c   Yuan, Qipeng ^a   Yang, Ming ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b Huaian No 2 Hospital   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES;

ESOPHAGEAL CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN CANCER; NEW MECHANISMS; NON-CODING RNAS; TUMOR SUPPRESSORS;

RNA;

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 101; MICRORNA 217; PROTEIN B MYB; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN; MESSENGER RNA; MIRN101 MICRORNA, HUMAN; MIRN217 MICRORNA, HUMAN;

ARTICLE; CANCER INHIBITION; CCT4 GENE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CTHRC1 GENE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE; GENE OVEREXPRESSION; GENE SILENCING; HNF4G GENE; HUMAN; HUMAN CELL; MALAT1 GENE; MIA2 GENE; ONCOGENE; PROTEIN EXPRESSION; ROBO1 GENE; TRANSCRIPTION REGULATION; TUMOR INVASION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL MOTION; DRUG SCREENING; ENZYME IMMUNOASSAY; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; FLOW CYTOMETRY; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; WOUND HEALING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84922771430     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.596866     Document Type: Article

References (42)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J. (2009) Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249
2. Gao, Y. T., McLaughlin, J. K., Blot, W. J., Ji, B. T., Benichou, J., Dai, Q., and Fraumeni, J. F., Jr. (1994) Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int. J. Cancer 58, 192-196
3. Hu, J., Nyrén, O., Wolk, A., Bergström, R., Yuen, J., Adami, H. O., Guo, L., Li, H., Huang, G., and Xu, X. (1994) Risk factors for oesophageal cancer in northeast China. Int. J. Cancer 57, 38-46
4. Wu, C., Hu, Z., He, Z., Jia, W., Wang, F., Zhou, Y., Liu, Z., Zhan, Q., Liu, Y., Yu, D., Zhai, K., Chang, J., Qiao, Y., Jin, G., Liu, Z., Shen, Y., Guo, C., Fu, J., Miao, X., Tan, W., Shen, H., Ke, Y., Zeng, Y., Wu, T., and Lin, D. (2011) Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet. 43, 679-684
5. Wu, C., Kraft, P., Zhai, K., Chang, J., Wang, Z., Li, Y., Hu, Z., He, Z., Jia, W., Abnet, C. C., Liang, L., Hu, N., Miao, X., Zhou, Y., Liu, Z., Zhan, Q., Liu, Y., Qiao, Y., Zhou, Y., Jin, G., Guo, C., Lu, C., Yang, H., Fu, J., Yu, D., Freedman, N. D., Ding, T., Tan, W., Goldstein, A. M., Wu, T., Shen, H., Ke, Y., Zeng, Y., Chanock, S. J., Taylor, P. R., and Lin, D. (2012) Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat. Genet. 44, 1090-1097
6. Wang, L. D., Zhou, F. Y., Li, X. M., Sun, L. D., Song, X., Jin, Y., Li, J. M., Kong, G. Q., Qi, H., Cui, J., Zhang, L. Q., Yang, J. Z., Li, J. L., Li, X. C., Ren, J. L., et al. (2010) Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet. 42, 759-763
7. Abnet, C. C., Freedman, N. D., Hu, N., Wang, Z., Yu, K., Shu, X. O., Yuan, J. M., Zheng, W., Dawsey, S. M., Dong, L. M., Lee, M. P., Ding, T., Qiao, Y. L., Gao, Y. T., Koh, W. P., Xiang, Y. B., Tang, Z. Z., Fan, J. H., Wang, C., Wheeler, W., Gail, M. H., Yeager, M., Yuenger, J., Hutchinson, A., Jacobs, K. B., Giffen, C. A., Burdett, L., Fraumeni, J. F., Jr., Tucker, M. A., Chow, W. H., Goldstein, A. M., Chanock, S. J., and Taylor, P. R. (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 42, 764-767
8. Eichler, E. E., Flint, J., Gibson, G., Kong, A., Leal, S. M., Moore, J. H., and Nadeau, J. H. (2010) Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11, 446-450
9. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874
10. Tsai, M. C., Spitale, R. C., and Chang, H. Y. (2011) Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 71, 3-7
11. Rinn, J. L., and Chang, H. Y. (2012) Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166
12. Ambros, V. (2001) microRNAs: tiny regulators with great potential. Cell 107, 823-826
13. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
14. Ponting, C. P., Oliver, P. L., and Reik, W. (2009) Evolution and functions of long noncoding RNAs. Cell 136, 629-641
15. Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., Thomas, M., Berdel, W. E., Serve, H., and Müller-Tidow, C. (2003) MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage nonsmall cell lung cancer. Oncogene 22, 8031-8041
16. Lin, R., Maeda, S., Liu, C., Karin, M., and Edgington, T. S. (2007) A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26, 851-858
17. Tripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S. M., Wu, X., Zhang, Y., Gorospe, M., Prasanth, S. G., Lal, A., and Prasanth, K. V. (2013) Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 9, e1003368
18. Gutschner, T., Hämmerle, M., Eissmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Gross, M., Zörnig, M., MacLeod, A. R., Spector, D. L., and Diederichs, S. (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 73, 1180-1189
19. Ren, S., Liu, Y., Xu, W., Sun, Y., Lu, J., Wang, F., Wei, M., Shen, J., Hou, J., Gao, X., Xu, C., Huang, J., and Zhao, Y. (2013) Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J. Urol. 190, 2278-2287
20. Lai, M. C., Yang, Z., Zhou, L., Zhu, Q. Q., Xie, H. Y., Zhang, F., Wu, L. M., Chen, L. M., and Zheng, S. S. (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 29, 1810-1816
21. Schmidt, L. H., Spieker, T., Koschmieder, S., Schäffers, S., Humberg, J., Jungen, D., Bulk, E., Hascher, A., Wittmer, D., Marra, A., Hillejan, L., Wiebe, K., Berdel, W. E., Wiewrodt, R., and Muller-Tidow, C. (2011) The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J. Thorac. Oncol. 6, 1984-1992
22. Xu, C., Yang, M., Tian, J., Wang, X., and Li, Z. (2011) MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int. J. Oncol. 39, 169-175
23. Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K., and Akimitsu, N. (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584, 4575-4580
24. Jalali, S., Bhartiya, D., Lalwani, M. K., Sivasubbu, S., and Scaria, V. (2013) Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS ONE 8, e53823
25. Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., Tramontano, A., and Bozzoni, I. (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369
26. Zhang, Z., Zhu, Z., Watabe, K., Zhang, X., Bai, C., Xu, M., Wu, F., and Mo, Y. Y. (2013) Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ. 20, 1558-1568
27. Leucci, E., Patella, F., Waage, J., Holmstrøm, K., Lindow, M., Porse, B., Kauppinen, S., and Lund, A. H. (2013) microRNA-9 targets the long noncoding RNA MALAT1 for degradation in the nucleus. Sci. Rep. 3, 2535
28. Han, Y., Liu, Y., Zhang, H., Wang, T., Diao, R., Jiang, Z., Gui, Y., and Cai, Z. (2013) Hsa-miR-125b suppresses bladder cancer development by downregulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 587, 3875-3882
29. Zhang, X., Wei, J., Zhou, L., Zhou, C., Shi, J., Yuan, Q., Yang, M., and Lin, D. (2013) A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis 34, 2309-2313
30. Zhou, C., Liu, J., Li, Y., Liu, L., Zhang, X., Ma, C. Y., Hua, S. C., Yang, M., and Yuan, Q. (2011) microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma. FEBS Lett. 585, 1828-1834
31. Zhou, L., Zhang, X., Li, Z., Zhou, C., Li, M., Tang, X., Lu, C., Li, H., Yuan, Q., and Yang, M. (2013) Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma. PLoS ONE 8, e64331
32. Liu, L., Zhou, C., Zhou, L., Peng, L., Li, D., Zhang, X., Zhou, M., Kuang, P., Yuan, Q., Song, X., and Yang, M. (2012) Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer, and colorectal cancer. Carcinogenesis 33, 119-123
33. Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M., Jr., Jungkamp, A. C., Munschauer, M., Ulrich, A., Wardle, G. S., Dewell, S., Zavolan, M., and Tuschl, T. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129-141
34. Wilusz, J. E., Freier, S. M., and Spector, D. L. (2008) 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 135, 919-932
35. Hutchinson, J. N., Ensminger, A. W., Clemson, C. M., Lynch, C. R., Lawrence, J. B., and Chess, A. (2007) A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains.BMC Genomics 8, 39
36. Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., Bubulya, P. A., Blencowe, B. J., Prasanth, S. G., and Prasanth, K. V. (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925-938
37. Yang, L., Lin, C., Liu, W., Zhang, J., Ohgi, K. A., Grinstein, J. D., Dorrestein, P. C., and Rosenfeld, M. G. (2011) ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147, 773-788
38. Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., Brenner, J. C., Yu, J., Kim, J. H., Han, B., Tan, P., Kumar-Sinha, C., Lonigro, R. J., Palanisamy, N., Maher, C. A., and Chinnaiyan, A. M. (2008) Genomic loss of microRNA- 101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322, 1695-1699
39. Wang, H. J., Ruan, H. J., He, X. J., Ma, Y. Y., Jiang, X. T., Xia, Y. J., Ye, Z. Y., and Tao, H. Q. (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer 46, 2295-2303
40. Su, H., Yang, J. R., Xu, T., Huang, J., Xu, L., Yuan, Y., and Zhuang, S. M. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142
41. Zhao, W. G., Yu, S. N., Lu, Z. H., Ma, Y. H., Gu, Y. M., and Chen, J. (2010) The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31, 1726-1733
42. Li, H., Zhao, J., Zhang, J. W., Huang, Q. Y., Huang, J. Z., Chi, L. S., Tang, H. J., Liu, G. Q., Zhu, D. J., and Ma, W. M. (2013) MicroRNA-217, downregulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation, and migration. Neoplasma 60, 511-515